Nakornthon Hospital PCL (BKK:NKT)
Thailand · Delayed Price · Currency is THB 3.840
+0.020 (0.52%)
At close: Jun 12, 2026
Nakornthon Hospital PCL Income Statement
Financials in millions THB. Fiscal year is January - December.
Millions THB. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Operating Revenue | 1,978 | 1,986 | 1,986 | 2,004 | 1,937 | 1,524 |
Other Revenue | 34.22 | 35.06 | 34.49 | 33.21 | 20.43 | 17.93 |
| 2,012 | 2,021 | 2,020 | 2,037 | 1,958 | 1,542 | |
Revenue Growth (YoY) | -0.32% | 0.05% | -0.81% | 4.04% | 26.97% | 11.97% |
Cost of Revenue | 1,449 | 1,422 | 1,401 | 1,386 | 1,307 | 1,100 |
Gross Profit | 563.09 | 599.47 | 619.87 | 651.01 | 650.54 | 442.06 |
Selling, General & Admin | 353.77 | 341.26 | 322.94 | 293.13 | 257.11 | 223.22 |
Other Operating Expenses | - | - | - | - | -4.85 | -4 |
Operating Expenses | 353.77 | 341.26 | 322.94 | 293.13 | 252.26 | 219.22 |
Operating Income | 209.32 | 258.21 | 296.94 | 357.88 | 398.28 | 222.84 |
Interest Expense | -5.59 | -5.6 | -11.69 | -4.82 | -0.01 | -0.03 |
EBT Excluding Unusual Items | 203.73 | 252.61 | 285.25 | 353.06 | 398.27 | 222.81 |
Gain (Loss) on Sale of Assets | - | - | - | - | 0.51 | 0.53 |
Pretax Income | 203.73 | 252.61 | 285.25 | 353.06 | 398.78 | 223.34 |
Income Tax Expense | 56.79 | 57.25 | 51.54 | 70.77 | 77.88 | 40.1 |
Net Income | 146.94 | 195.35 | 233.7 | 282.29 | 320.91 | 183.24 |
Net Income to Common | 146.94 | 195.35 | 233.7 | 282.29 | 320.91 | 183.24 |
Net Income Growth | -35.45% | -16.41% | -17.21% | -12.03% | 75.13% | 107.70% |
Shares Outstanding (Basic) | 535 | 535 | 406 | 400 | 400 | 400 |
Shares Outstanding (Diluted) | 535 | 535 | 406 | 400 | 400 | 400 |
Shares Change (YoY) | 21.69% | 31.80% | 1.48% | - | - | - |
EPS (Basic) | 0.27 | 0.37 | 0.58 | 0.71 | 0.80 | 0.46 |
EPS (Diluted) | 0.27 | 0.37 | 0.58 | 0.71 | 0.80 | 0.46 |
EPS Growth | -46.95% | -36.58% | -18.42% | -12.03% | 75.13% | 107.70% |
Free Cash Flow | -607.27 | -510.72 | 105.34 | 211.88 | 267.3 | 308.94 |
Free Cash Flow Per Share | -1.14 | -0.95 | 0.26 | 0.53 | 0.67 | 0.77 |
Dividend Per Share | 0.180 | 0.180 | 0.180 | 1.000 | 0.250 | 0.110 |
Dividend Growth | - | - | -82.00% | 300.00% | 127.27% | 120.00% |
Gross Margin | 27.98% | 29.66% | 30.68% | 31.96% | 33.23% | 28.67% |
Operating Margin | 10.40% | 12.77% | 14.70% | 17.57% | 20.34% | 14.45% |
Profit Margin | 7.30% | 9.66% | 11.57% | 13.86% | 16.39% | 11.88% |
Free Cash Flow Margin | -30.18% | -25.27% | 5.21% | 10.40% | 13.65% | 20.04% |
EBITDA | 345.98 | 383.34 | 417.89 | 482.27 | 505.23 | 324.8 |
EBITDA Margin | 17.19% | 18.96% | 20.68% | 23.68% | 25.81% | 21.07% |
D&A For EBITDA | 136.65 | 125.13 | 120.95 | 124.39 | 106.95 | 101.96 |
EBIT | 209.32 | 258.21 | 296.94 | 357.88 | 398.28 | 222.84 |
EBIT Margin | 10.40% | 12.77% | 14.70% | 17.57% | 20.34% | 14.45% |
Effective Tax Rate | 27.87% | 22.66% | 18.07% | 20.04% | 19.53% | 17.96% |
Revenue as Reported | 2,012 | 2,021 | 2,020 | 2,037 | 1,963 | 1,552 |
Advertising Expenses | - | 18.62 | 18.27 | 18.31 | 10.26 | 10.93 |